Dirk Finsinger

1.4k total citations
17 papers, 1.2k citations indexed

About

Dirk Finsinger is a scholar working on Molecular Biology, Immunology and Allergy and Organic Chemistry. According to data from OpenAlex, Dirk Finsinger has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Immunology and Allergy and 5 papers in Organic Chemistry. Recurrent topics in Dirk Finsinger's work include Cell Adhesion Molecules Research (6 papers), Computational Drug Discovery Methods (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Dirk Finsinger is often cited by papers focused on Cell Adhesion Molecules Research (6 papers), Computational Drug Discovery Methods (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Dirk Finsinger collaborates with scholars based in Germany, United Kingdom and Sweden. Dirk Finsinger's co-authors include Horst Kessler, Roland Haubner, Beate Diefenbach, Alfred Jonczyk, Patricia Schaffner, Berthold Nies, Martin Kantlehner, J. Meyer, Günter Hölzemann and Simon L. Goodman and has published in prestigious journals such as Angewandte Chemie International Edition, Biochemistry and Kidney International.

In The Last Decade

Dirk Finsinger

17 papers receiving 1.1k citations

Peers

Countries citing papers authored by Dirk Finsinger

Since Specialization

Citations

This map shows the geographic impact of Dirk Finsinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Finsinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Finsinger more than expected).

Fields of papers citing papers by Dirk Finsinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Finsinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Finsinger. The network helps show where Dirk Finsinger may publish in the future.

Co-authorship network of co-authors of Dirk Finsinger

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Finsinger. A scholar is included among the top collaborators of Dirk Finsinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Finsinger. Dirk Finsinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	The European Lead Factory: Results from a decade of collaborative, public–private, drug discovery programs 2024 ·Drug Discovery Today ·Herman van Vlijmen, Andrew Pannifer, (unknown), (unknown), (unknown), Ola Engkvist, Jean‐Yves Ortholand, Markus Wagener, James Duffy, Dirk Finsinger, Jeremy Davis, (unknown), Jon S. B. de Vlieger	2
2	The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Phenotypic Drug Discovery 2021 ·ChemMedChem ·Jean Quancard, Anders Bach, Brian J. Cox, (unknown), Dirk Finsinger, Stéphanie M. Guéret, Ingo V. Hartung, Stefan Laufer, (unknown), Gianluca Sbardella, Hannes F. Koolman	8
3	The European Federation for Medicinal Chemistry (EFMC) Best Practice Initiative: Validating Chemical Probes 2020 ·ChemMedChem ·Jean Quancard, Brian J. Cox, Dirk Finsinger, Stéphanie M. Guéret, Ingo V. Hartung, Hannes F. Koolman, (unknown), Gianluca Sbardella, Stefan Laufer	9
4	Discovery of novel 7-azaindoles as PDK1 inhibitors 2016 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Eugen Merkul, Thomas J. J. Müller, Christina Esdar, Thorsten Knöchel, Timo Heinrich, Hans‐Peter Buchstaller, Hartmut E. Greiner, Dieter Dorsch, Dirk Finsinger, (unknown), (unknown), Ulrich Grädler	16
5	Design and synthesis of isoquinolines and benzimidazoles as RAF kinase inhibitors 2011 ·Bioorganic & Medicinal Chemistry Letters ·Hans‐Peter Buchstaller, Lars T. Burgdorf, Dirk Finsinger, Frank Stieber, Christian Sirrenberg, Christiane Amendt, Matthias Grell, Frank T. Zenke, Mireille Krier	17
6	The discovery and optimization of hexahydro-2H-pyrano[3,2-c]quinolines (HHPQs) as potent and selective inhibitors of the mitotic kinesin-5 2010 ·Bioorganic & Medicinal Chemistry Letters ·Kai Schiemann, Dirk Finsinger, Frank T. Zenke, Christiane Amendt, Thorsten Knöchel, (unknown), Hans‐Peter Buchstaller, Ulrich Emde, (unknown), Soheila Anzali	56
7	Access to Variously Substituted 5,6,7,8‐Tetrahydro‐3H‐quinazolin‐4‐ones via Diels–Alder Adducts of Phenyl Vinyl Sulfone to Cyclobutene‐Annelated Pyrimidinones 2006 ·European Journal of Organic Chemistry ·(unknown), Vladimir N. Belov, Shamil Nizamov, Karsten Rauch, Dirk Finsinger, Armin de Meijere	21
8	Surface Coating with Cyclic RGD Peptides Stimulates Osteoblast Adhesion and Proliferation as well as Bone Formation 2000 ·ChemBioChem ·Martin Kantlehner, Patricia Schaffner, Dirk Finsinger, J. Meyer, Alfred Jonczyk, Beate Diefenbach, Berthold Nies, Günter Hölzemann, Simon L. Goodman, Horst Kessler	250
9	Protective copolymers for nonviral gene vectors: synthesis, vector characterization and application in gene delivery 2000 ·Gene Therapy ·Dirk Finsinger, Jean-Serge Rémy, Patrick Erbacher, Christian A. Koch, Christian Plank	115
10	Intervesicle Cross-Linking with Integrin α_IIbβ₃and Cyclic-RGD-Lipopeptide. A Model of Cell-Adhesion Processes 2000 ·Biochemistry ·Bin Hu, Dirk Finsinger, (unknown), Zeno Guttenberg, M. Bärmann, Horst Kessler, (unknown), Luis Moroder, Jochen Böhm, Wolfgang Baumeister, Sen‐Fang Sui, E. Sackmann	44
11	Surface Coating with Cyclic RGD Peptides Stimulates Osteoblast Adhesion and Proliferation as well as Bone Formation 2000 ·ChemBioChem ·Martin Kantlehner, Patricia Schaffner, Dirk Finsinger, J. Meyer, Alfred Jonczyk, Beate Diefenbach, Berthold Nies, Günter Hölzemann, Simon L. Goodman, Horst Kessler	11
12	Selective RGD-Mediated Adhesion of Osteoblasts at Surfaces of Implants 1999 ·Angewandte Chemie International Edition ·Martin Kantlehner, Dirk Finsinger, J. Meyer, Patricia Schaffner, Alfred Jonczyk, Beate Diefenbach, Berthold Nies, Horst Kessler	109
13	Selektive RGD-vermittelte Adhäsion von Osteoblasten an Implantat-Oberflächen 1999 ·Angewandte Chemie ·Martin Kantlehner, Dirk Finsinger, J. Meyer, Patricia Schaffner, Alfred Jonczyk, Beate Diefenbach, Berthold Nies, Horst Kessler	29
14	Selektive RGD-vermittelte Adhäsion von Osteoblasten an Implantat-Oberflächen 1999 ·Angewandte Chemie ·Martin Kantlehner, Dirk Finsinger, J. Meyer, Patricia Schaffner, Alfred Jonczyk, Beate Diefenbach, Berthold Nies, Horst Kessler	2
15	Two novel probes reveal tubular and vascular Arg-Gly-Asp (RGD) binding sites in the ischemic rat kidney 1997 ·Kidney International ·Victor Romanov, Eisei Noiri, (unknown), Dirk Finsinger, Horst Kessler, Michael S. Goligorsky	46
16	Stereoisomeric Peptide Libraries and Peptidomimetics for Designing Selective Inhibitors of the α_vβ₃ Integrin for a New Cancer Therapy 1997 ·Angewandte Chemie International Edition in English ·Roland Haubner, Dirk Finsinger, Horst Kessler	372
17	Design of superactive and selective integrin receptor antagonists containing the RGD sequence 1995 ·Letters in Peptide Science ·Horst Kessler, Beate Diefenbach, Dirk Finsinger, Armin Geyer, Marion Gurrath, Simon L. Goodman, Günter Hölzemann, Roland Haubner, Alfred Jonczyk, Gerhard Müller, Erich Graf von Roedern, (unknown)	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact